Life Sciences Call 2011 - Linking Research and Patients' NeedsLS11-026

Serum-Autoantibody testing for early diagnosis of Breast Cancer


Serum-Autoantibody testing for early diagnosis of Breast Cancer
Principal Investigator:
Andreas Weinhaeusel
Projekttitel:
Serum-Autoantibody testing for early diagnosis of Breast Cancer
Status:
Abgeschlossen (01.10.2011 – 31.03.2015) 42 Monate
Fördersumme:
€ 579.300

 
Kurzzusammenfassung:

Tumour auto-antibodies in the serum of patients are early indicators for breast-cancer and can be detected by protein-chips using a few micro liters of patients' serum.
Protein chip technology (AIT) and phage-display (BOKU) will be used for identification of auto-antibody-based markers. Therefore serum of patients with malignant and benign breast tumours and healthy controls will be used (MUW), then a prototype test will be developed and validated using 1200 serum samples. Hence an assay will be developed which in addition to mammography improves the detection and diagnosis of early-stage breast cancer. This project has a high long-term impact because early detection of breast cancers significantly enhances therapeutic success and women's chances of survival.

 

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind technisch notwendig, während andere uns helfen, diese Website zu verbessern oder zusätzliche Funktionalitäten zur Verfügung zu stellen. Weitere Informationen